Chengpeng Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chengpeng Chen has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
Curtis G. Jones
Department of Chemistry and Biochemistry
10 shared publicationsGiraso Keza Monia Kabandana
Department of Chemistry and Biochemistry
8 shared publications- John A. Terrell
Department of Chemistry and Biochemistry
6 shared publications - R. Scott Martin
Department of Chemistry Saint Louis University St. Louis Missouri USA
6 shared publications Tao Zhang
Department of Chemistry and Biochemistry, University of Maryland Baltimore County, Baltimore, USA
6 shared publicationsAlexandra D. Townsend
Department of Chemistry
4 shared publications
Latest Publications
- Open Access
- 22 May 2026
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 418  (14) , 1-11
Reusable 3D-printed microfluidic-on-fabric with modular electrodes for point-of-care Na+ and K+ detection in various biofluids
In this study, we present a new 3D-printed microfluidic-on-fabric sensor platform that allows for point-of-care (POC) detection in various biofluids. Using the low-cost FDM 3D-printing, we developed a method to form well-defined microfluidic features on fabric substrates (3D-printed microfluidic-on-fabric), which could modularly house an electrode pad with desired electrodes targeting different analytes. The 3D-printed microfluidic-on-fabric integrates the comfort, robustness, and reusability (after washing) of fabric substrates with the precision, modularity, and scalability offered by 3D-printed structures. We showcased the application of the sensor platform for Naâş and Kâş detections with lab-made ion-selective electrode pads. The electrodes showed high reusability, in addition to the robust Nernst sensitivity, accuracy, selectivity, and reproducibility (linear range = 5â500 mM; LOD(Naâş) = 1.5 mM and LOD(K + ) = 1.6 mM). The sensor platform was successfully implemented to detect Naâş and Kâş in a range of biofluids, including urine, saliva, and sweat, with results validated by ion chromatographic methods. An Arduino board (~ $20) was programmed to couple to the sensor for data collection, transducing, processing, and transferring to a computer. Overall, this is a new sensor platform that is low-cost, reusable, modular, and customizable, representing an advancement in POC sensor development.
- 22 May 2026
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 418  (14) , 1-11
Open AccessReusable 3D-printed microfluidic-on-fabric with modular electrodes for point-of-care Na+ and K+ detection in various biofluids
In this study, we present a new 3D-printed microfluidic-on-fabric sensor platform that allows for point-of-care (POC) detection in various biofluids. Using the low-cost FDM 3D-printing, we developed a method to form well-defined microfluidic features on fabric substrates (3D-printed microfluidic-on-fabric), which could modularly house an electrode pad with desired electrodes targeting different analytes. The 3D-printed microfluidic-on-fabric integrates the comfort, robustness, and reusability (after washing) of fabric substrates with the precision, modularity, and scalability offered by 3D-printed structures. We showcased the application of the sensor platform for Naâş and Kâş detections with lab-made ion-selective electrode pads. The electrodes showed high reusability, in addition to the robust Nernst sensitivity, accuracy, selectivity, and reproducibility (linear range = 5â500 mM; LOD(Naâş) = 1.5 mM and LOD(K + ) = 1.6 mM). The sensor platform was successfully implemented to detect Naâş and Kâş in a range of biofluids, including urine, saliva, and sweat, with results validated by ion chromatographic methods. An Arduino board (~ $20) was programmed to couple to the sensor for data collection, transducing, processing, and transferring to a computer. Overall, this is a new sensor platform that is low-cost, reusable, modular, and customizable, representing an advancement in POC sensor development.
- 11 November 2025
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 26  (12) , 8475-8483
Extracellular Matrix Microstructures Directly Regulate Glutathione Bioavailability in Human Hepatocytes
Recent works in mechanobiology have investigated overarching changes in cell behavior in response to extracellular matrix (ECM) stiffness. Nonetheless, little is known about how key metabolic pathways and critical metabolites are regulated by the ECM microstructures. Glutathione, a tripeptide predominantly synthesized in the liver, is a critical molecule used for the metabolism of certain xenobiotics and the reduction of oxidative species. Here, we report that the ECM microstructures can directly regulate the glutathione bioavailability and synthesis. By preparing a fibrous scaffold to mimic healthy native liver ECM and a flat substrate mimicking severe fibrotic conditions with the same surface chemistry, we found that the fibrous ECM upregulated glutathione levels in hepatocytes with enhanced antioxidation capacity. Mechanistic studies involving reducing and increasing integrin β1 activation suggested that ECM microstructures, integrin β1, and intracellular hepatic glutathione synthesis were mechanistically linked. These results represented an unprecedented discovery in mechanobiology regarding ECM microstructures' role in regulating the hepatic metabolome, i.e., glutathione bioavailability, which can provide new insights into understanding and treating fibrotic liver diseases.
- 11 November 2025
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 26  (12) , 8475-8483
Extracellular Matrix Microstructures Directly Regulate Glutathione Bioavailability in Human Hepatocytes
Recent works in mechanobiology have investigated overarching changes in cell behavior in response to extracellular matrix (ECM) stiffness. Nonetheless, little is known about how key metabolic pathways and critical metabolites are regulated by the ECM microstructures. Glutathione, a tripeptide predominantly synthesized in the liver, is a critical molecule used for the metabolism of certain xenobiotics and the reduction of oxidative species. Here, we report that the ECM microstructures can directly regulate the glutathione bioavailability and synthesis. By preparing a fibrous scaffold to mimic healthy native liver ECM and a flat substrate mimicking severe fibrotic conditions with the same surface chemistry, we found that the fibrous ECM upregulated glutathione levels in hepatocytes with enhanced antioxidation capacity. Mechanistic studies involving reducing and increasing integrin β1 activation suggested that ECM microstructures, integrin β1, and intracellular hepatic glutathione synthesis were mechanistically linked. These results represented an unprecedented discovery in mechanobiology regarding ECM microstructures' role in regulating the hepatic metabolome, i.e., glutathione bioavailability, which can provide new insights into understanding and treating fibrotic liver diseases.
- Open Access
- 23 September 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Reusable 3D-Printed microfluidic-on-Fabric with Modular Electrodes for Point-of-Care Na+ and K+ Detection in Various Biofluids
In this study, we present a new 3D-printed microfluidic-on-fabric sensor platform that allows for point-of-care (POC) detection in various biofluids. Using the low-cost FDM 3D-printing, we developed a method to form well-defined microfluidic features on fabric substrates (3D-printed microfluidic-on-fabric), which could modularly house an electrode pad with desired electrodes targeting different analytes. The 3D-printed microfluidic-on-fabric integrates the comfort, robustness, and reusability (after washing) of fabric substrates with the precision, modularity, and scalability offered by 3D-printed structures. We showcased the application of the sensor platform for Naâş and Kâş detections with lab-made ion-selective electrode pads. The electrodes showed high reusability, in addition to the robust Nernst sensitivity, accuracy, selectivity, and reproducibility. The sensors platform was successfully implemented to detect Naâş and Kâş in a range of biofluids, including urine, saliva, and sweat, with results validated by ion chromatographic methods. An Arduino board (~$20) was programmed to couple to the sensor for data collection, transducing, processing, and transferring to a computer. Overall, this is a new sensor platform that is low-cost, reusable, modular, and customizable, representing an advancement in POC sensor development.
- 23 September 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessReusable 3D-Printed microfluidic-on-Fabric with Modular Electrodes for Point-of-Care Na+ and K+ Detection in Various Biofluids
In this study, we present a new 3D-printed microfluidic-on-fabric sensor platform that allows for point-of-care (POC) detection in various biofluids. Using the low-cost FDM 3D-printing, we developed a method to form well-defined microfluidic features on fabric substrates (3D-printed microfluidic-on-fabric), which could modularly house an electrode pad with desired electrodes targeting different analytes. The 3D-printed microfluidic-on-fabric integrates the comfort, robustness, and reusability (after washing) of fabric substrates with the precision, modularity, and scalability offered by 3D-printed structures. We showcased the application of the sensor platform for Naâş and Kâş detections with lab-made ion-selective electrode pads. The electrodes showed high reusability, in addition to the robust Nernst sensitivity, accuracy, selectivity, and reproducibility. The sensors platform was successfully implemented to detect Naâş and Kâş in a range of biofluids, including urine, saliva, and sweat, with results validated by ion chromatographic methods. An Arduino board (~$20) was programmed to couple to the sensor for data collection, transducing, processing, and transferring to a computer. Overall, this is a new sensor platform that is low-cost, reusable, modular, and customizable, representing an advancement in POC sensor development.
- 1 August 2025
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 10  (8) , 5694-5703
A Wearable Enzymatic Uric Acid Sensor on Microfluidics-on-Fabrics with Octadecane (C18) Modification
This study introduces a technology for creating microfluidic devices on garments and an octadecane (C18) modification of the fabric-based microfluidics, representing a novel wearable chemical sensing platform. Integrating microfluidics directly into garments eliminates the need for wearing additional sweat-sensing devices but provides natural comfort, minimal risk of allergies, and capillary actions to drive sweat flows. The C18 modification of the detection zones significantly improved the functionality of fabric-based microfluidics, particularly by enabling efficient and robust enzyme capture for enzymatic assays to analyze sweat metabolites. Our findings demonstrated that the enzyme remained strongly in the detection zone, with minimal loss, even under rigorous continuous flow washing conditions, which is critical because enzyme loss by sweat flow will keep compromising the analytical performance. Moreover, the C18 chemically introduced could retain uricase's activity stably during storage for weeks, indicating promises for mass production and storage of such wearable sensors. Next, a microfluidic-on-hospital gown was developed with immobilized uricase to quantify sweat uric acid levels of a wearer, which yielded accurate results validated by an LC-MS method. Overall, this research represents a significant advancement in wearable microfluidics for enzymatic molecular sensing in sweat.
- 1 August 2025
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 10  (8) , 5694-5703
A Wearable Enzymatic Uric Acid Sensor on Microfluidics-on-Fabrics with Octadecane (C18) Modification
This study introduces a technology for creating microfluidic devices on garments and an octadecane (C18) modification of the fabric-based microfluidics, representing a novel wearable chemical sensing platform. Integrating microfluidics directly into garments eliminates the need for wearing additional sweat-sensing devices but provides natural comfort, minimal risk of allergies, and capillary actions to drive sweat flows. The C18 modification of the detection zones significantly improved the functionality of fabric-based microfluidics, particularly by enabling efficient and robust enzyme capture for enzymatic assays to analyze sweat metabolites. Our findings demonstrated that the enzyme remained strongly in the detection zone, with minimal loss, even under rigorous continuous flow washing conditions, which is critical because enzyme loss by sweat flow will keep compromising the analytical performance. Moreover, the C18 chemically introduced could retain uricase's activity stably during storage for weeks, indicating promises for mass production and storage of such wearable sensors. Next, a microfluidic-on-hospital gown was developed with immobilized uricase to quantify sweat uric acid levels of a wearer, which yielded accurate results validated by an LC-MS method. Overall, this research represents a significant advancement in wearable microfluidics for enzymatic molecular sensing in sweat.
- 29 April 2025
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 26  (6) , 3356-3363
Extracellular Matrix Microstructures Modulate Hepatic Methionine Cycle and Methylations
The field of mechanobiology has grown in the past decade, but limited studies investigate how the extracellular matrix affects the cell metabolome. The methionine cycle involves the catabolism and regeneration of methionine through the donation and recovery of a single methyl group; this methyl group can methylate DNA, RNA, and proteins to alter gene expression and protein-protein interactions. Through studying cells cultured on fibrous (mimicking healthy extracellular matrice (ECM)) and flat (mimicking severely fibrotic ECM) substrates, we observed an increase in methionine cycle enzyme expression in cells on the flat substrate. We also present how the methionine cycle is modulated by the ECM through transmembrane protein integrin β1. By inhibiting integrin activation through the ligand-mimicking peptide RGD, we observed that the methionine cycle was protected from alteration. The results presented provide insight into possible therapeutic targets for fibrotic diseases and knowledge of mechanisms by which the ECM alters cell processes.
- 29 April 2025
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 26  (6) , 3356-3363
Extracellular Matrix Microstructures Modulate Hepatic Methionine Cycle and Methylations
The field of mechanobiology has grown in the past decade, but limited studies investigate how the extracellular matrix affects the cell metabolome. The methionine cycle involves the catabolism and regeneration of methionine through the donation and recovery of a single methyl group; this methyl group can methylate DNA, RNA, and proteins to alter gene expression and protein-protein interactions. Through studying cells cultured on fibrous (mimicking healthy extracellular matrice (ECM)) and flat (mimicking severely fibrotic ECM) substrates, we observed an increase in methionine cycle enzyme expression in cells on the flat substrate. We also present how the methionine cycle is modulated by the ECM through transmembrane protein integrin β1. By inhibiting integrin activation through the ligand-mimicking peptide RGD, we observed that the methionine cycle was protected from alteration. The results presented provide insight into possible therapeutic targets for fibrotic diseases and knowledge of mechanisms by which the ECM alters cell processes.
- 24 April 2025
- Published by American Chemical Society (ACS) in ACS Pharmacology & Translational Science
- Vol. 8  (5) , 1424-1434
3D Hepatocyte Model with Composite Nanofibers That Reproduced Human In Vivo Drug Clearance Profiles
This study presents a novel in vitro 3D hepatocyte model that contains a nanofibrous scaffold designed to mimic the extracellular matrix (ECM) of the human liver, both structurally and biochemically. A modular 3D-printed device housing the ECM scaffold was also developed, readily fitting in well plates. HepaRG hepatocytes cultured on the scaffold exhibited enhanced metabolic activity compared to traditional 2D cultures, indicating improved hepatocyte functionality. Drug clearance studies with lidocaine, clozapine, and fluoxetine demonstrated significantly faster clearance rates on the scaffold, closely aligning with in vivo results from the literature, while 2D cultures showed limited metabolic capacity. This model offers a physiologically relevant platform for hepatocyte studies. The findings underscore the model's potential to advance preclinical drug development by replicating liver-specific functions in vitro.
- 24 April 2025
- Published by American Chemical Society (ACS) in ACS Pharmacology & Translational Science
- Vol. 8  (5) , 1424-1434
3D Hepatocyte Model with Composite Nanofibers That Reproduced Human In Vivo Drug Clearance Profiles
This study presents a novel in vitro 3D hepatocyte model that contains a nanofibrous scaffold designed to mimic the extracellular matrix (ECM) of the human liver, both structurally and biochemically. A modular 3D-printed device housing the ECM scaffold was also developed, readily fitting in well plates. HepaRG hepatocytes cultured on the scaffold exhibited enhanced metabolic activity compared to traditional 2D cultures, indicating improved hepatocyte functionality. Drug clearance studies with lidocaine, clozapine, and fluoxetine demonstrated significantly faster clearance rates on the scaffold, closely aligning with in vivo results from the literature, while 2D cultures showed limited metabolic capacity. This model offers a physiologically relevant platform for hepatocyte studies. The findings underscore the model's potential to advance preclinical drug development by replicating liver-specific functions in vitro.
- 8 April 2025
- Published by American Chemical Society (ACS) in ACS Applied Polymer Materials
- Vol. 7  (8) , 4759-4770
Chemical Addition of Octadecane (C18) to 3D-Printed Parts for Surface Activation with Example Applications
- 8 April 2025
- Published by American Chemical Society (ACS) in ACS Applied Polymer Materials
- Vol. 7  (8) , 4759-4770
Chemical Addition of Octadecane (C18) to 3D-Printed Parts for Surface Activation with Example Applications
- Open Access
- 15 March 2025
- Published by Elsevier in Journal of Pharmaceutical Analysis
- Vol. 15  (12)
A customizable continuous and near real-time TEER platform to study anti-cancer drug toxicity in barrier tissues
- 15 March 2025
- Published by Elsevier in Journal of Pharmaceutical Analysis
- Vol. 15  (12)
Open AccessA customizable continuous and near real-time TEER platform to study anti-cancer drug toxicity in barrier tissues
- Open Access
- 4 March 2025
- Published by American Chemical Society (ACS) in ChemRxiv
A 3D Hepatocyte Model with Composite Nanofibers that Reproduced Human in vivo Drug Clearance Profiles
This study presents a novel in vitro 3D hepatocyte model that contains a nanofibrous scaffold designed to mimic the extracellular matrix (ECM) of the human liver, both structurally and biochemically. A modular 3D-printed device housing the ECM scaffold was also developed, readily fitting in well plates. HepaRG hepatocytes cultured on the scaffold exhibited enhanced metabolic activity compared to traditional 2D cultures, indicating improved hepatocyte functionality. Drug clearance studies with lidocaine, clozapine, and fluoxetine demonstrated significantly faster clearance rates on the scaffold, closely aligning with in vivo results from literature, while 2D cultures showed limited metabolic capacity. This model offers a physiologically relevant platform for hepatocyte studies. The findings underscore the modelâs potential to advance preclinical drug development by replicating liver-specific functions in vitro.
- 4 March 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessA 3D Hepatocyte Model with Composite Nanofibers that Reproduced Human in vivo Drug Clearance Profiles
This study presents a novel in vitro 3D hepatocyte model that contains a nanofibrous scaffold designed to mimic the extracellular matrix (ECM) of the human liver, both structurally and biochemically. A modular 3D-printed device housing the ECM scaffold was also developed, readily fitting in well plates. HepaRG hepatocytes cultured on the scaffold exhibited enhanced metabolic activity compared to traditional 2D cultures, indicating improved hepatocyte functionality. Drug clearance studies with lidocaine, clozapine, and fluoxetine demonstrated significantly faster clearance rates on the scaffold, closely aligning with in vivo results from literature, while 2D cultures showed limited metabolic capacity. This model offers a physiologically relevant platform for hepatocyte studies. The findings underscore the modelâs potential to advance preclinical drug development by replicating liver-specific functions in vitro.
- 18 February 2025
- Published by Wiley in Electrophoresis
- Vol. 46  (16) , 1174-1184
3DâPrinted MicrofluidicâBased Cell Culture System With Analysis to Investigate Macrophage Activation
In this paper, we describe the development of 3Dâprinted microfluidic cell culture devices that can be coupled with a circulation system to study the dynamics of both intracellular and extracellular (release) processes. Key to this approach is the ability to quantitate key analytes on a minutes timescale with either onâline (in this study, quantitating nitric oxide production using an amperometric flow cell) or offâline (in this work, quantitating intracellular itaconate production with LC/MS) analytical measurements. To demonstrate the usefulness of this approach, we chose to study macrophage polarization as a function of the extracellular matrix (silk) fiber size, a major area of research in tissue engineering. It was found that the use of larger fibers (1280 nm vs. smaller 512 nm fibers) led to increases in the production of both nitric oxide and itaconate. These findings set the foundation for future research for the creation of finely tuned microfluidic 3D cell culture approaches in areas where flow and the extracellular matrix play a significant role in barrier transport and where integrated analysis of key markers is needed.
- 18 February 2025
- Published by Wiley in Electrophoresis
- Vol. 46  (16) , 1174-1184
3DâPrinted MicrofluidicâBased Cell Culture System With Analysis to Investigate Macrophage Activation
In this paper, we describe the development of 3Dâprinted microfluidic cell culture devices that can be coupled with a circulation system to study the dynamics of both intracellular and extracellular (release) processes. Key to this approach is the ability to quantitate key analytes on a minutes timescale with either onâline (in this study, quantitating nitric oxide production using an amperometric flow cell) or offâline (in this work, quantitating intracellular itaconate production with LC/MS) analytical measurements. To demonstrate the usefulness of this approach, we chose to study macrophage polarization as a function of the extracellular matrix (silk) fiber size, a major area of research in tissue engineering. It was found that the use of larger fibers (1280 nm vs. smaller 512 nm fibers) led to increases in the production of both nitric oxide and itaconate. These findings set the foundation for future research for the creation of finely tuned microfluidic 3D cell culture approaches in areas where flow and the extracellular matrix play a significant role in barrier transport and where integrated analysis of key markers is needed.